Home / Blog / Retatrutide Delivers Some of the Strongest Weight Loss Results Ever Seen in a Phase 3 Trial
RetatrutideEli LillyWeight Loss ResearchObesity ResearchGLP-1GIPTriple AgonistPeptidesResearch PeptidesWeight ManagementCarbon-12 Labs
Retatrutide Delivers Some of the Strongest Weight Loss Results Ever Seen in a Phase 3 Trial
New Phase 3 data from Eli Lilly shows retatrutide producing average weight loss of up to 28.3%, with some participants losing over 30% of their body weight after extended treatment.